Skip to content
HomeLatest newsGlobal Trial Finder: Why it just got easier to enroll in a Janssen clinical study
Global Trial Finder

Global Trial Finder: Why it just got easier to enroll in a Janssen clinical study

More than 35,000 of the world’s most dedicated scientists and innovators work for the Janssen Pharmaceutical Companies of Johnson & Johnson, helping to research and develop new ways to treat and prevent some of the world’s most complex diseases.

But there’s another key component that’s necessary when it comes to finding new therapies for conditions like Alzheimer’s disease, rheumatoid arthritis and cancer: you.

Janssen Research & Development routinely conducts clinical trials to evaluate investigational medications and treatment regimens, and that requires the participation of hundreds—sometimes even thousands—of volunteers.

But finding enough willing and qualified participants can often be a challenge.

Enter the Janssen Global Trial Finder, an easy-to-use database of clinical trials that are currently accepting new participants for a variety of diseases. People interested in enrolling in a study can search by medical condition and geographic location.

“We understand both the health-related reasons people seek to participate in clinical trials, and the motivation to help others who may face similar experiences in the future,” says Bert Hartog, Ph.D., Director and Clinical Trial Innovation Lead at Janssen. “So we wanted to offer a resource for easily accessing our clinical trials globally—a resource that can enable us to continue to advance innovative medicines to treat, prevent, intercept and cure some of the most complex diseases of our time.”

More from Johnson & Johnson

What’s the difference between a heart attack and cardiac arrest?

Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.

What you need to know about Johnson & Johnson’s 2023 transparency report

The annual report has just been released—here are key takeaways that showcase the company’s commitment to creating a more sustainable, equitable and innovative healthcare system.

Diversity in the OR: 3 barrier-breaking female surgeons share their stories

Only one in 10 orthopedic surgeons in the U.S. are women. Learn how Johnson & Johnson is working to change that stat.